Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Public ClinicalTrials.gov record NCT00372996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-arm Randomized Open Label Phase 2 Study Of Cp-751,871 In Combination With Exemestane Versus Exemestane Alone As First Line Treatment For Postmenopausal Patients With Hormone Receptor Positive Advanced Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To test the efficacy of CP-751,871 combined with exemestane in the treatment of postmenopausal patients with hormone positive advanced breast cancer
Study identification
- NCT ID
- NCT00372996
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2007 (Type not available)
- Primary completion
- Sep 2012 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Oct 28, 2015
2007 – 2014
United States locations
- U.S. sites
- 33
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Medical Center - La Jolla | La Jolla | California | 92037 | — |
| UCSD Moores Cancer Center | La Jolla | California | 92093 | — |
| UCSD Medical Center - Hillcrest | San Diego | California | 92103 | — |
| Washington Cancer Institute (WCI) at Washington Hospital Center (WHC) | Washington D.C. | District of Columbia | 20010-3017 | — |
| Florida Cancer Research Institute | Davie | Florida | 33328 | — |
| Florida Cancer Research Institute | Plantation | Florida | 33324 | — |
| Central Baptist Hospital | Lexington | Kentucky | 40503 | — |
| Lexington Oncology Associates | Lexington | Kentucky | 40503 | — |
| Bluegrass Hematology/Oncology, PSC | Lexington | Kentucky | 40504 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Bringham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute (DFCI) | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 2215 | — |
| University of Minnesota Medical Center-Fairview, Riverside Campus | Minneapolis | Minnesota | 55454 | — |
| University of Minnesota Cancer Center | Minneapolis | Minnesota | 55455 | — |
| University Of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
| Alamance Regional Medical Center - Cancer Center | Burlington | North Carolina | 27215-8700 | — |
| Duke University Medical Center - Morris Cancer Center Clinics | Durham | North Carolina | 27710 | — |
| Duke University Medical Center- Department of Medicine Oncology | Durham | North Carolina | 27710 | — |
| Duke University Medical Center-Duke Cancer Center | Durham | North Carolina | 27710 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Duke University School Of Medicine | Durham | North Carolina | 27710 | — |
| Texas Oncology - PA Collins Building 5th Floor | Dallas | Texas | 75246-2006 | — |
| Baylor College Of Medicine (Bcm) | Houston | Texas | 77030 | — |
| Baylor College of Medicine Breast Center | Houston | Texas | 77030 | — |
| Fletcher Allen Healthcare | Burlington | Vermont | 05401-1473 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| Fletcher Allen Hospital MCHV Campus | Burlington | Vermont | 05401 | — |
| Pharmacist, Investigational Drug Service | Burlington | Vermont | 05401 | — |
| Fletcher Allen Healthcare | Burlington | Vermont | 05405 | — |
| Fletcher Allan Health Care | Burlington | Vermont | 5401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00372996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2015 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00372996 live on ClinicalTrials.gov.